About Us

Zero Nephrotoxicity

Unlike existing "low-risk" options, Nuvira™ eliminates kidney damage risk.

Nuvira™ is a groundbreaking IV contrast agent designed to be completely non-nephrotoxic. We aim to revolutionize diagnostic imaging by eliminating the risk of contrast-induced nephropathy (CIN), a significant concern with current contrast agents.

We are in the early stages of research and development, focusing on building our non-nephrotoxic contrast agent model

Universal Applicability

Safe for all patients, including those with pre-existing kidney conditions.

Multi-Modality Compatibility

Suitable for CT, MRI, and angiography.

Cost-Effective

Reduces healthcare costs by eliminating CIN-related complications and extended hospital stays.

Our Approach

1

2

Innovate

Develop cutting-edge, kidney-safe contrast agents

Educate

Together, we'll collect and format all the relevant data.

Collaborate

Partner with hospitals and research institutions to continually improve our product

3

Why Nuvira?

First-to-market with a truly non-nephrotoxic contrast agent

Commitment to patient safety without sacrificing image quality

Cross-disciplinary team of medical experts and chemical engineers

What Do Doctors Say?

”As a radiologist, I've always been concerned about the risks of contrast agents, especially for patients with kidney issues. The idea of Nuvira’s non-nephrotoxic contrast agent is incredibly promising. If it performs as expected, it could completely change how we approach diagnostic imaging for high-risk patients.”

- Migues Reyes, MD, Radiology

Join Our Journey

Be part of the revolution in safe medical imaging.

Frequently Asked Questions

What makes your contrast agent different from others on the market?

Our contrast agent is completely non-nephrotoxic, eliminating the risk of contrast-induced nephropathy (CIN), making it safer for patients, especially those with kidney conditions.

Is your contrast agent compatible with all imaging modalities?

Yes, our agent is designed for use in multiple modalities, including CT, MRI, and angiography.

Is your product available for clinical use?

Not yet; we are currently in the early stages of research and development and are working toward clinical trials.

Who can benefit from your contrast agent?

Our agent is safe for all patients, including those with pre-existing kidney conditions or at high risk for CIN.

How can I stay updated on your progress?

You can reach us by nuvira@mediloquy.com We are always happy to answer your questions.

Get in touch

Feel free to reach out with any questions about our ongoing research or if you're interested in joining our team!